Menu
Annual · values202520242023202220212020201920182017
Operating Cash Flow-675000 USD-12.43 M USD-18.71 M USD-41.66 M USD-39.53 M USD-30.66 M USD-31.63 M USD-14.52 M USD-17.53 M USD
Depreciation & Amortization5.77 M USD4.38 M USD5.43 M USD3.45 M USD2.09 M USD1.13 M USD774000 USD722000 USD1.01 M USD
Stock-Based Compensation25.52 M USD25.87 M USD24.06 M USD23.06 M USD16.87 M USD11.93 M USD7.46 M USD2.31 M USD1.44 M USD
Capital Expenditures8.41 M USD10.50 M USD7.80 M USD9.51 M USD6.39 M USD2.56 M USD2.44 M USD942000 USD478000 USD
Cash Flow from Investing4.16 M USD12.62 M USD-59.80 M USD-2.81 M USD51.58 M USD-62.92 M USD13.49 M USD-97.83 M USD-478000 USD
Cash Flow from Financing3.38 M USD1.96 M USD90.93 M USD2.20 M USD-1.71 M USD136.40 M USD3.49 M USD115.15 M USD12.86 M USD
Dividends Paid
Stock Buybacks38000 USD73000 USD0 USD
Free Cash Flow-9.09 M USD-22.92 M USD-26.51 M USD-51.16 M USD-45.92 M USD-33.22 M USD-34.07 M USD-15.46 M USD-18.01 M USD

Si-Bone Inc. is a prominent medical device company specializing in the development and commercialization of minimally invasive surgical implants for the treatment of sacroiliac joint dysfunction. Known for its iFuse Implant System, the company's primary product aims to alleviate pain and improve mobility in patients suffering from lower back issues. Si-Bone Inc. plays a crucial role in the healthcare sector, particularly within the orthopedic and spinal surgery industries. The company focuses on innovation in surgical technologies and techniques, aiming to offer safer and more effective alternatives to traditional procedures. With a strong emphasis on clinical research and education for healthcare providers, Si-Bone Inc. contributes significantly to advancing patient outcomes. Catering primarily to hospitals and surgical centers, the firm maintains a dynamic presence in both domestic and international markets. Headquartered in Santa Clara, California, Si-Bone Inc.'s innovative solutions continue to influence the evolving landscape of healthcare technology and patient care.